Angiotensin II-dependent loss of cardiac function: Mechanisms and pharmacological targets attenuating this effect

Journal of Cellular Physiology

Volumn 217, Issue 1, 2008, Pages 242-249

  Mufti, Solaiman ^a   Wenzel, Sibylle ^a   Euler, Gerhild ^a   Piper, Hans Michael ^a   Schlüter, Klaus Dieter ^a,b  

^a Physiologisches Institut   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APROTININ; GLYCOGEN SYNTHASE KINASE 3; NEUTRALIZING ANTIBODY; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA1; ATP2A2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HORMONE ACTION; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WISTAR RAT; ANIMAL; CELL CULTURE; DRUG EFFECT; METABOLISM; MUSCLE CONTRACTION; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

RATTUS;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; MALE; MUSCLE CONTRACTION; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 49649128837     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21501     Document Type: Article

References (49)

1. Anwar A, Taimor G, Korkususz H, Schreckenberg R, Berndt T, Abdallah Y, Piper HM, Schlüter K-D. 2005. PKC-independent signal transduction pathways increase SERCA2 expression in adult rat cardio myocytes. J Mol Cell Cardiol 39:911-919.
2. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad C, Crow MT, Lakatta EG. 1994. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res 75:23-32.
3. Cingolani HE, Villa-Abrille MC, Cornelli M, Nolly A, Ennis IL, Garciarena C, Suburo AM, Torbidoni V, Correa MV, Camilion de Hurtado MC, Aiello EA. 2006. The positive inotropic effect of angiotensin II. Hypertension 47:727-734.
4. Del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A, Hajjar RJ. 1999. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100:2308-2311.
5. Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. 2002. Statins, 3-hydroxy-3-methlyglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol 40:611-617.
6. Doggrell S. 1989. The effects of atriopeptin and angiotensin on the rat right ventricle. Gen Pharmacol 20:253-257.
7. Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LMD. 2005. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 46:426-432.
8. Fuller SJ, Gaitanaki CJ, Sudgen PH. 1990. Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Biochem J 266:727-736.
9. Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AJ. 2006. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occuring in response to pressure overload. J Am Coll Cardiol 47:817-826.
10. Hamawaki M, Coffmann TM, Lashus A, Koide M, Tile MR, Oliveiro MI, de Freyte G, Cooper G IV, Carabello BA. 1998. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am J Physiol 274:H868-H873.
11. Harade K, Komuro I, Zou Y, Kudoh S, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y. 1998. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ Res 82:779-785.
12. Henriksen JH. 1991. Degradation of circulating renin and angiotensin. In: Henriksen JH, editor. Degradation of bioactive substances: Physiology and pathophysiology. London, UK: CRC press. pp 113-119.
13. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H. 1993. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium: An in vitro study under experimental conditions. Circulation 88:1228-1237.
14. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino A, Kioke A, Nogami F, Marumo F, Hiroe M. 1993. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92:398-403.
15. Ju H, Scammell-La Fleur T, Dixon IM. 1996. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 28:1119-1128.
16. Kass RS, Blair ML. 1981. Effects of angiotensin II on membrane current in cardiac Purkinje fibres. J Mol Cell Cardiol 13:797-809.
17. Kobayashi M, Furukawa Y, Chiba S. 1978. Positive chronotropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol 50:17-25.
18. 2+ ATPase expression. Circulation 113:2724-2732.
19. Langer M, Lüttecke D, Schlüter K-D. 2003. Mechanism of the positive contractile effect of nitric oxide on rat ventricular cardiomyocytes with positive force/frequency relationship. Pflügers Arch Eur J Physiol 447:289-297.
20. Lundblad A, Gonzalez-Serratos H, Inesi G, Swanson J, Paolini P. 1986. Patterns of sarcomere activation, temperature dependence, and effect of ryanodine in chemically skinned cardiac fibres. J Gen Physiol 87:885-905.
21. Meissner A, Min J-Y, Simon R. 1998. Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol 30:2507-2518.
22. Michael A, Haq S, Chen X, Hsich E, Cui L, Walters B, Shao Z, Bhattacharya K, Kilter H, Huggins G, Andreucci M, Perissamy M, Solomon RS, Liao R, Patten R, Molkentin JD, Force T. 2004. Glycogen synthase kinase-3β regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem 279:21383-21393.
23. Moravec CS, Schluchter MD, Paranandi L, Czerska B, Stewrat RW, Rosenkranz E, Bond M. 1990. Inotropic effects of angiotensin II on human cardiac mucles in vitro. Circulation 82:1973-1984.
24. Neyses L, Vetter H. 1989. Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II. J Hypertens 7:S104-S105.
25. Onohara N, Nishida M, Inoue R, Kobayashi H, Sunimoto H, Sato Y, Mory Y, Nagao T, Kurose H. 2006. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 25:5305-5316.
26. Palomeque J, Sapia L, Hajjar RJ, Mattiazzi A, Vila Petroff M. 2006. Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. AM J Physiol Heart Circ Physiol 290:H96-H106.
27. 2+ homeostasis and cardiac contractility. J Mol Cell Cardiol 33:1053-1063.
28. Pfeffer JM, Pfeffer MA. 1988. Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure. Am J Med 83:37-44.
29. Pinto YM, Pinto-Sietsma S-J, Philipp T, Engler S, Koßmehl P, Hocher B, Marquardt H, Sethmann S, Lauster R, Merker H-J, Paul M. 2000. Reduction in left ventricular messenger RNA for transforming growth factor beta (1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat. Hypertension 36:747-754.
30. Plotkin B, Kaidanovich O, Talior I, Eldar-Finkelman H. 2003. Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3. J Pharmacol Exp Ther 305:974-980.
31. Ruf S, Piper HM, Schlüter K-D. 2002. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro. Pflügers Arch Eur J Physiol 443:483-490.
32. Sabri A, Lucchesi PA. 2006. ANG II and cardiac myocytes contractility: p38 is not stressed out. Am J Physiol Heart Circ Physiol 290:H72-H73.
33. Sakurai K, Norota I, Tanaka H, Kubota I, Tomoike H, Endoh M. 2002. Negative inotropic effect of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci 70:1173-1184.
34. Schlüter K-D, Schreiber D. 2005. Adult ventricular cardiomyocytes: Isolation and culture. Meth Mol Biol 290:305-314.
35. Schlüter K-D, Zhou XJ, Piper HM. 1995. Induction of hypertrophic responsiveness to isoproterenol by TGF-β in adult rat cardiomyocytes. Am J Physiol 269:C1311-C1316.
36. 2+-dependent PKC isoforms unmasks ERK-dependent hypertrophic growth evoked by phenylephrine in adult ventricular cardiomyocytes. Cardiovasc Res 63:553-560.
37. Schröder D, Heger J, Piper HM, Euler G. 2006. Angiotensin II stimulates apoptosis via TGF-β1 signaling in ventricular cardiomyocytes of rat. J Mol Med 84:975-983.
38. Scott AL, Chang RS, Lotti VJ, Siegl PK. 1992. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD121981, in rabbit heart. J Pharmacol Exp Ther 261:931-935.
39. Taimor G, Schlüter K-D, Frischkopf K, Flesch M, Rosenkranz S, Piper HM. 1999. Autocrine regulation of TGF-β expression in adult cardiomyocytes. J Mol Cell Cardiol 313:2127-2136.
40. Taimor G, Schlüter K-D, Piper HM. 2001. Hypertrophy-associated gene induction after beta-adrenergic stimulation in adult cardiomyocytes. J Mol Cell Cardiol 33:503-511.
41. The SOLVD investigators. 1991. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 325:293-302.
42. Vahebi S, Ota A, Li M, Warren CM, de Tombe PP, Wang Y, Solaro RS. 2007. P38 MAPK induced dephosphorylation of α-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ Res 100:408-415.
43. Venema RC, Kuo JF. 1993. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J Biol Chem 268:2705-2711.
44. Wada H, Zile MR, Ivester CZ, Cooper G IV, McDermott PJ. 1996. Comperative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture. Am J Physiol 271:H29-H37.
45. 2+ exchange in activation of excitation-contraction coupling in rat ventricular myocytes. J Physiol 493:529-542.
46. Wenzel S, Taimor G, Piper HM, Schlüter K-D. 2001. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB J 15:2291-2293.
47. Wenzel S, Müller C, Piper HM, Schlüter K-D. 2005. p38 MAP kinase in cultured adult rat ventricular cardiomyocytes: Expression and involvement in hypertrophic signalling. Eur J Heart Fail 7:453-460.
48. 2+]i in isolated perfused rat hearts. Am Heart J 122:786-794.
49. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94:110-118.